[Intermittent claudication and risk factors among men 40 to 59 years of age based on the data of a prospective

Terapevticheskii Arkhiv
|January 1, 1989
PubMed

Insights

Intermittent claudication (IC) is prevalent in 0.89% of men aged 40-59. IC significantly correlates with hypercholesterolemia and smoking, and increases myocardial infarction risk and lethality.

Area of Science:

  • Cardiovascular epidemiology
  • Vascular medicine
  • Public health

Context:

  • Intermittent claudication (IC) is a common manifestation of peripheral artery disease.
  • Risk factors for cardiovascular disease are well-established, but their specific impact on IC requires further investigation.
  • Understanding IC prevalence and associated risk factors is crucial for targeted prevention strategies.

Purpose:

  • To determine the prevalence of intermittent claudication (IC) in men aged 40-59.
  • To identify risk factors associated with IC in this demographic.
  • To analyze the relationship between IC and the incidence and lethality of acute myocardial infarction (AMI).

Summary:

  • A study examined 6117 men aged 40-59, finding an age-standardized IC prevalence of 0.89%.
  • Significant correlations were observed between IC and hypercholesterolemia and tobacco smoking.
  • Men with IC exhibited higher rates of myocardial infarction and increased AMI lethality compared to those without IC.

Impact:

  • This study highlights hypercholesterolemia and smoking as key risk factors for IC in middle-aged men.
  • The findings underscore the significant association between IC and adverse cardiovascular outcomes, including AMI.
  • Results can inform public health initiatives and clinical practice for cardiovascular risk management.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...